Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F11%3A10099386" target="_blank" >RIV/00179906:_____/11:10099386 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11150/11:10099386
Result on the web
<a href="http://www.springerlink.com/content/m7w3515v97175162/fulltext.pdf" target="_blank" >http://www.springerlink.com/content/m7w3515v97175162/fulltext.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00380-010-0114-0" target="_blank" >10.1007/s00380-010-0114-0</a>
Alternative languages
Result language
angličtina
Original language name
Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction
Original language description
Ischemia-modified albumin (IMA) is a laboratory biomarker of cardiac ischemia. Our study aims to determine whether IMA can estimate or represent to any degree the extent of myocardial ischemia. We expect that the higher the marker of cardiac necrosis (maximum value after serial measurements) the greater the preceding cardiac ischemia, indicated by IMA in patients diagnosed with STEMI prior to direct percutaneous coronary intervention (PCI). We studied 216 patients indicated for direct PCI with a diagnosis of ST elevation myocardial infarction.We observed that there was no significant association between increase in IMA and CK-MB (R2 = 0.011, p = 0.637). Similar results were noted in the case of cardiac troponin T (cTnT) (R2 = 0.0068, p = 0.483). We concluded that IMA does not provede information regarding the extent and scope of cardiac ischemia in patients with STEMI.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NR9174" target="_blank" >NR9174: Determination and significance of resistance to antiplatelet therapy</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Heart and Vessels
ISSN
0910-8327
e-ISSN
—
Volume of the periodical
26
Issue of the periodical within the volume
6
Country of publishing house
DE - GERMANY
Number of pages
6
Pages from-to
622-627
UT code for WoS article
000297175700009
EID of the result in the Scopus database
—